PERM_HUMAN - dbPTM
PERM_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PERM_HUMAN
UniProt AC P05164
Protein Name Myeloperoxidase
Gene Name MPO
Organism Homo sapiens (Human).
Sequence Length 745
Subcellular Localization Lysosome.
Protein Description Part of the host defense system of polymorphonuclear leukocytes. It is responsible for microbicidal activity against a wide range of organisms. In the stimulated PMN, MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, and other toxic intermediates that greatly enhance PMN microbicidal activity..
Protein Sequence MGVPFFSSLRCMVDLGPCWAGGLTAEMKLLLALAGLLAILATPQPSEGAAPAVLGEVDTSLVLSSMEEAKQLVDKAYKERRESIKQRLRSGSASPMELLSYFKQPVAATRTAVRAADYLHVALDLLERKLRSLWRRPFNVTDVLTPAQLNVLSKSSGCAYQDVGVTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAARASFVTGVNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8PhosphorylationMGVPFFSSLRCMVDL
CCCCCHHCCEEEEEC
18.0624719451
90PhosphorylationSIKQRLRSGSASPME
HHHHHHHCCCCCHHH
41.5123532336
92PhosphorylationKQRLRSGSASPMELL
HHHHHCCCCCHHHHH
27.1628450419
94PhosphorylationRLRSGSASPMELLSY
HHHCCCCCHHHHHHH
26.8628857561
103AcetylationMELLSYFKQPVAATR
HHHHHHHHCCHHCCH
45.5261193
132PhosphorylationLLERKLRSLWRRPFN
HHHHHHHHHHCCCCC
42.6024719451
139N-linked_GlycosylationSLWRRPFNVTDVLTP
HHHCCCCCHHHCCCH
38.1616335952
172AcetylationVTCPEQDKYRTITGM
CCCCCCCCCHHHHHH
36.0026822725
187PhosphorylationCNNRRSPTLGASNRA
CCCCCCCCCCCCCCH
38.7923312004
191PhosphorylationRSPTLGASNRAFVRW
CCCCCCCCCCHHEEE
25.6723312004
231PhosphorylationVALARAVSNEIVRFP
HHHHHHHHCCCCCCC
27.9724247654
316SulfationCIPFFRSCPACPGSN
CCHHHHCCCCCCCCC
1.847840679
316OxidationCIPFFRSCPACPGSN
CCHHHHCCCCCCCCC
1.847840679
316Cysteine sulfenic acid (-SOH)CIPFFRSCPACPGSN
CCHHHHCCCCCCCCC
1.84-
322O-linked_GlycosylationSCPACPGSNITIRNQ
CCCCCCCCCCCHHHH
15.3628657654
323N-linked_GlycosylationCPACPGSNITIRNQI
CCCCCCCCCCHHHHH
41.1416740002
323N-linked_GlycosylationCPACPGSNITIRNQI
CCCCCCCCCCHHHHH
41.1420332087
355N-linked_GlycosylationPLARNLRNMSNQLGL
HHHHHHHHHHHHHCH
41.211334087
355N-linked_GlycosylationPLARNLRNMSNQLGL
HHHHHHHHHHHHHCH
41.211334087
357PhosphorylationARNLRNMSNQLGLLA
HHHHHHHHHHHCHHH
25.6025278378
391N-linked_GlycosylationDDPCLLTNRSARIPC
CCCCCCCCCCCCCCE
35.561334087
391N-linked_GlycosylationDDPCLLTNRSARIPC
CCCCCCCCCCCCCCE
35.561334087
428PhosphorylationREHNRLATELKSLNP
HHHHHHHHHHHHHCC
46.5820736484
432PhosphorylationRLATELKSLNPRWDG
HHHHHHHHHCCCCCH
46.10-
470PhosphorylationLPLVLGPTAMRKYLP
HHHHHCHHHHHHHCC
31.1527499020
481PhosphorylationKYLPTYRSYNDSVDP
HHCCCCCCCCCCCCH
20.2023403867
482PhosphorylationYLPTYRSYNDSVDPR
HCCCCCCCCCCCCHH
17.6223403867
483N-linked_GlycosylationLPTYRSYNDSVDPRI
CCCCCCCCCCCCHHH
36.0116740002
500PhosphorylationVFTNAFRYGHTLIQP
HHHHHHHHCCCCHHC
13.5518083107
516PhosphorylationMFRLDNRYQPMEPNP
HEECCCCCCCCCCCC
24.1929083192
516Nitrated tyrosineMFRLDNRYQPMEPNP
HEECCCCCCCCCCCC
24.19-
528PhosphorylationPNPRVPLSRVFFASW
CCCCCCHHHHHHHEH
21.96-
625SumoylationGTVLRNLKLARKLME
HHHHHHHHHHHHHHH
43.58-
625SumoylationGTVLRNLKLARKLME
HHHHHHHHHHHHHHH
43.58-
687PhosphorylationWENEGVFSMQQRQAL
CCCCCCCCHHHHHHH
17.1829802988
698PhosphorylationRQALAQISLPRIICD
HHHHHHCCCCEEECC
21.9024719451
707PhosphorylationPRIICDNTGITTVSK
CEEECCCCCCEEEEC
19.4029978859
710PhosphorylationICDNTGITTVSKNNI
ECCCCCCEEEECCCE
23.6129978859
711PhosphorylationCDNTGITTVSKNNIF
CCCCCCEEEECCCEE
22.3629978859
713PhosphorylationNTGITTVSKNNIFMS
CCCCEEEECCCEECC
27.8129978859
720PhosphorylationSKNNIFMSNSYPRDF
ECCCEECCCCCCCCC
16.3321552520
723PhosphorylationNIFMSNSYPRDFVNC
CEECCCCCCCCCCCC
13.4121552520
729N-linked_GlycosylationSYPRDFVNCSTLPAL
CCCCCCCCCCCCCCC
17.6420332087
729N-linked_GlycosylationSYPRDFVNCSTLPAL
CCCCCCCCCCCCCCC
17.6417623646

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PERM_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PERM_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PERM_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of PERM_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
254600Myeloperoxidase deficiency (MPOD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PERM_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-355 AND ASN-391, AND MASSSPECTROMETRY.
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry.";
Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.;
J. Proteome Res. 5:1493-1503(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-323 AND ASN-483, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-139 AND ASN-483, AND MASSSPECTROMETRY.
"Glycosylation pattern of mature dimeric leukocyte and recombinantmonomeric myeloperoxidase: glycosylation is required for optimalenzymatic activity.";
Van Antwerpen P., Slomianny M.C., Boudjeltia K.Z., Delporte C.,Faid V., Calay D., Rousseau A., Moguilevsky N., Raes M., Vanhamme L.,Furtmueller P.G., Obinger C., Vanhaeverbeek M., Neve J.,Michalski J.C.;
J. Biol. Chem. 285:16351-16359(2010).
Cited for: PROTEIN SEQUENCE OF 49-53, SUBUNIT, GLYCOSYLATION AT ASN-323; ASN-355;ASN-391; ASN-483 AND ASN-729, AND MASS SPECTROMETRY.

TOP